VivoSeq
Other

Morphine

0

Pipeline Programs↗

3

Active Trials↗

5

Companies Involved↗

Morphine is an early-stage landscape with 0 programs across 5 companies. The most active players are Pfizer, Sumitomo Pharma America, Inc., Javelin Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

95/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalSumitomo Pharma America, Inc. logo

Sumitomo Pharma America, Inc.

0 programs

PreclinicalJ

Javelin Pharmaceuticals

0 programs

PreclinicalH

Halozyme Therapeutics

0 programs

PreclinicalA

Alexza Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

52

clinical trials

Completed38 · 73%
Unknown status9 · 17%
Withdrawn2 · 4%
Recruiting2 · 4%
Active, not recruiting1 · 2%

Clinical Trials

Trial Activity

52 trials

Apomorphine in Severe Brain-injured Patients
Recruiting·UUniversity of Liege·Phase 2/3·NCT05213169·48 enrolled
Intrathecal Morphine for Recovery and Outcomes After VATS
Recruiting·—·N/A·NCT07231926·52 enrolled
Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties
Active, not recruiting·HHôpital Privé Sévigné·N/A·NCT06832995·300 enrolled
Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions
Completed·RRanbaxy Inc.·Phase 1·NCT01665209·24 enrolled
A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes
Completed·Sumitomo Pharma America, Inc. logoSumitomo Pharma America, Inc.·Phase 2·NCT03292016·8 enrolled
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)
Completed·JJavelin Pharmaceuticals·Phase 1·NCT00474799·32 enrolled
INFUSE Morphine Study
Completed·HHalozyme Therapeutics·Phase 3·NCT00593281·13 enrolled
Optimizing the Use of Morphine in Pre-Term Neonates
Completed·JJohn van den Anker·Phase 2·NCT00494429·33 enrolled
The Effects of Morphine on Desflurane Consumption and Recovery Time
Completed·—·Phase 4·NCT02362022·90 enrolled
Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions
Completed·RRoxane Laboratories·N/A·NCT00994942·18 enrolled
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Completed·NNorwegian University of Science and Technology·Phase 3·NCT00201539·19 enrolled
Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg
Completed·UUniversity Hospital, Toulouse·Phase 4·NCT00237731·106 enrolled
Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery
Completed·—·Phase 4·NCT01150474·103 enrolled
A Relation of Morphine-induced Itch and Pain Processing
Completed·—·N/A·NCT04115462·24 enrolled
Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine
Completed·—·N/A·NCT04672382·26 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)